311 related articles for article (PubMed ID: 18053988)
1. Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels.
Christensen R; Marcussen AB; Wörtwein G; Knudsen GM; Aznar S
Exp Neurol; 2008 Mar; 210(1):164-71. PubMed ID: 18053988
[TBL] [Abstract][Full Text] [Related]
2. Commentary: Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels.
Lanctôt KL; Herrmann N; Rothenburg LS
Exp Neurol; 2008 Aug; 212(2):251-4. PubMed ID: 18544454
[No Abstract] [Full Text] [Related]
3. Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons.
Wang DC; Chen SS; Lee YC; Chen TJ
Neurosci Lett; 2006 May; 398(1-2):78-82. PubMed ID: 16412575
[TBL] [Abstract][Full Text] [Related]
4. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons.
Chen TJ; Wang DC; Chen SS
J Neurosci Res; 2009 Aug; 87(10):2297-307. PubMed ID: 19301428
[TBL] [Abstract][Full Text] [Related]
6. BDNF downregulates 5-HT(2A) receptor protein levels in hippocampal cultures.
Trajkovska V; Santini MA; Marcussen AB; Thomsen MS; Hansen HH; Mikkelsen JD; Arneberg L; Kokaia M; Knudsen GM; Aznar S
Neurochem Int; 2009 Dec; 55(7):697-702. PubMed ID: 19563850
[TBL] [Abstract][Full Text] [Related]
7. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Jing W; Guo F; Cheng L; Zhang JF; Qi JS
Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
[TBL] [Abstract][Full Text] [Related]
8. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat.
Jacobsen JP; Mørk A
Brain Res; 2006 Sep; 1110(1):221-5. PubMed ID: 16876769
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-beta(25-35) impairs memory and increases NO in the temporal cortex of rats.
Limón ID; Díaz A; Mendieta L; Chamorro G; Espinosa B; Zenteno E; Guevara J
Neurosci Res; 2009 Feb; 63(2):129-37. PubMed ID: 19084561
[TBL] [Abstract][Full Text] [Related]
10. Catalpol ameliorates beta amyloid-induced degeneration of cholinergic neurons by elevating brain-derived neurotrophic factors.
Wang Z; Liu Q; Zhang R; Liu S; Xia Z; Hu Y
Neuroscience; 2009 Nov; 163(4):1363-72. PubMed ID: 19635525
[TBL] [Abstract][Full Text] [Related]
11. The effect of intrahippocampal beta amyloid (1-42) peptide injection on oxidant and antioxidant status in rat brain.
Cetin F; Dincer S
Ann N Y Acad Sci; 2007 Apr; 1100():510-7. PubMed ID: 17460216
[TBL] [Abstract][Full Text] [Related]
12. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
[TBL] [Abstract][Full Text] [Related]
13. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
[TBL] [Abstract][Full Text] [Related]
14. Intensification of long-term memory deficit by chronic stress and prevention by nicotine in a rat model of Alzheimer's disease.
Alkadhi KA; Srivareerat M; Tran TT
Mol Cell Neurosci; 2010 Nov; 45(3):289-96. PubMed ID: 20624465
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
16. The neurotoxin 2'-NH2-MPTP degenerates serotonin axons and evokes increases in hippocampal BDNF.
Luellen BA; Szapacs ME; Materese CK; Andrews AM
Neuropharmacology; 2006 Mar; 50(3):297-308. PubMed ID: 16288930
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus.
Stepanichev MY; Zdobnova IM; Zarubenko II; Moiseeva YV; Lazareva NA; Onufriev MV; Gulyaeva NV
Physiol Behav; 2004 Feb; 80(5):647-55. PubMed ID: 14984798
[TBL] [Abstract][Full Text] [Related]
18. Messenger RNA and protein expression analysis of voltage-gated potassium channels in the brain of Abeta(25-35)-treated rats.
Pan Y; Xu X; Tong X; Wang X
J Neurosci Res; 2004 Jul; 77(1):94-9. PubMed ID: 15197742
[TBL] [Abstract][Full Text] [Related]
19. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.
Szapacs ME; Mathews TA; Tessarollo L; Ernest Lyons W; Mamounas LA; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):81-92. PubMed ID: 15589338
[TBL] [Abstract][Full Text] [Related]
20. Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
Lu P; Mamiya T; Lu LL; Mouri A; Niwa M; Hiramatsu M; Zou LB; Nagai T; Ikejima T; Nabeshima T
J Pharmacol Exp Ther; 2009 Oct; 331(1):319-26. PubMed ID: 19638571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
